Results 11 to 20 of about 389,924 (238)
Proliferative Vitreoretinopathy: A Reappraisal
Journal of Clinical Medicine, 2023 Proliferative vitreoretinopathy (PVR) remains the main cause of failure after retinal detachment (RD) surgery. Despite the development of modern technologies and sophisticated techniques for the management of RD, the growth of fibrocellular membranes within the vitreous cavity and on both sides of the retinal surface, as well as intraretinal fibrosis ...
Carpineto, Paolo +2 more
openaire +4 more sources
A Review of Innovations in Rhegmatogenous Retinal Detachment Surgical Techniques [PDF]
Journal of Ophthalmology, 2017 Rhegmatogenous retinal detachment (RRD) requires surgical intervention for its repair. There are variable techniques used for this purpose, and they are all being continuously refined.
Achia Nemet +4 more
doaj +4 more sources
Nature CommunicationsProliferative vitreoretinopathy is a vision-threatening response to penetrating ocular injury, for which there is no satisfactory treatment. In this disorder, retinal pigment epithelial cells, abandon their attachment to Bruch’s membrane on the scleral ...
Min Luo +7 more
doaj +2 more sources
Proliferative vitreoretinopathy
Zdravniški Vestnik, 2005 Background: Proliferative vitreoretinopathy (PVR) is a disease characterized by formation of membranes on both surfaces of the retina and vitreous base. PVR is a wound healing response which is inadequate and uncontrolled in the eye. Identifying the risk
Mojca Globočnik-Petrovič +1 more
doaj +3 more sources
Proliferative Vitreoretinopathy: A Review [PDF]
International Ophthalmology Clinics, 2019 Proliferative vitreoretinopathy (PVR) is the most common cause for failure of rhegmatogenous retinal detachment repair and is characterized by the growth and contraction of cellular membranes within the vitreous cavity and on both sides of the retinal surface as well as intraretinal fibrosis.
Sana, Idrees +2 more
openaire +3 more sources
Salinomycin inhibits proliferative vitreoretinopathy formation in a mouse model.
PLoS ONE, 2020 Proliferative vitreoretinopathy (PVR) is a progressive disease that develops in a subset of patients who undergo surgery for retinal detachment repair, and results in significant vision loss.
Alison M Heffer +5 more
doaj +2 more sources
A sustained dual drug delivery system for proliferative vitreoretinopathy
Drug Delivery, 2020 Proliferative vitreoretinopathy (PVR) is a significant threat for vision recovery from retinal detachment or ocular trauma. Currently, no approved pharmacological intervention to prevent PVR.
Ying Xiao +7 more
doaj +2 more sources
Risk factors for failure after primary vitrectomy with no scleral buckling for rhegmatogenous retinal detachment [PDF]
Revista Brasileira de Oftalmologia, 2023 Objective To assess pre-operative conditions that could influence primary anatomical success rate in a cohort of patients with rhegmatogenous retinal detachments (RRD) treated with primary vitrectomy and no scleral buckling.
Mariano Iros +4 more
doaj +1 more source
Proliferative vitreoretinopathy: an update on the current and emerging treatment options
Graefe's Archive for Clinical and Experimental Ophthalmology, 2023 Proliferative vitreoretinopathy (PVR) remains the main cause of failure in retinal detachment (RD) surgery and a demanding challenge for vitreoretinal surgeons.
L. Ferro Desideri +4 more
semanticscholar +2 more sources
Early and Pronounced PVR Reaction After Revitrectomy With Allogeneic Platelet Concentrate in Persistent Macular Hole. [PDF]
Case Rep Ophthalmol MedWe report two cases of pronounced development of proliferative vitreoretinopathy (PVR) within a few days after 23G revitrectomy with allogeneic platelet concentrate (PC) in persistent macular hole in 2023–2024. None of the cases had relevant risk factors for PVR development such as intraoperative retinal tears.
Fisel PC, Spitzer M, Özen A, Skevas C.
europepmc +2 more sources